Inhibitors of phosphatidylinositol-3-kinase in cancer therapy

Lignende værker

• Take your PIK: PI-3-kinase inhibitors race through the clinic and towards cancer therapy
  af: Ihle, Nathan T., et al.
  Udgivet: (2009)
• Class I phosphatidylinositol 3-kinase inhibitors for cancer therapy
  af: Zhao, Wennan, et al.
  Udgivet: (2017)
• Mutations in the phosphatidylinositol-3-kinase pathway predict for antitumor activity of the inhibitor PX-866 while oncogenic Ras is a dominant predictor for resistance
  af: Ihle, NathanT., et al.
  Udgivet: (2009)
• The skin and hair as surrogate tissues for measuring the target effect of inhibitors of phosphoinositide-3-kinase signaling.
  af: Williams, Ryan, et al.
  Udgivet: (2006)
• Phosphatidylinositol 3-kinase (PI3K) inhibitors as cancer therapeutics
  af: Akinleye, Akintunde, et al.
  Udgivet: (2013)